Business Description
Biora Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US74319F3055
Share Class Description:
BIORQ: Ordinary SharesDescription
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -5179.71 | |||||
OCF Margin % | -5148.32 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 7.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIORQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biora Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.892 | ||
| EPS (TTM) ($) | -13.04 | ||
| Beta | 1.06 | ||
| 3-Year Sharpe Ratio | -1.41 | ||
| 3-Year Sortino Ratio | -1.38 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.22 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.22 - 0.22 | ||
| Shares Outstanding (Mil) | 4.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biora Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biora Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-02 | In 149 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-02 | In 149 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 68 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-13 | In 68 days | ||
| General meeting for 2025 | 2026-09-10 | In 4 days | ||
| Second quarter earnings conference call for 2026 | 2026-09-07 | In 1 day | ||
| Second quarter earnings results for 2026 | 2026-09-07 | In 1 day | ||
| Third quarter earnings conference call for 2024 | 2024-11-14 16:30 | 2.49 (-7.78%) | ||
| Third quarter earnings results for 2024 | 2024-11-14 | 2.49 (-7.78%) | ||
| 0.1:1 Stock Split | 2024-10-18 | 5.54 (-4.02%) |
Show
Entries
Biora Therapeutics Inc Frequently Asked Questions
What is Biora Therapeutics Inc(BIORQ)'s stock price today?
The current price of BIORQ is $0.22. The 52 week high of BIORQ is $0.22 and 52 week low is $0.22.
When is next earnings date of Biora Therapeutics Inc(BIORQ)?
The next earnings date of Biora Therapeutics Inc(BIORQ) is 2026-09-07 Est..
Does Biora Therapeutics Inc(BIORQ) pay dividends? If so, how much?
Biora Therapeutics Inc(BIORQ) does not pay dividend.
Press Release
Articles on Biora Therapeutics Inc
No articles.